BIPOLAR DISORDERS, published by Wiley, is a leading international journal dedicated to advancing the understanding and treatment of bipolar disorders. Since its establishment in 1999, the journal has become a vital resource in the fields of Biological Psychiatry and Psychiatry and Mental Health, currently ranked in the Q2 category for Biological Psychiatry and Q1 for Psychiatry and Mental Health as of 2023. With impressive Scopus rankings, it stands at 75th out of 567 in Psychiatry and Mental Health and 11th out of 51 in Biological Psychiatry, reflecting its influential role in shaping mental health research. The journal not only focuses on empirical studies, reviews, and clinical reports but also encourages innovative methodological advancements in understanding bipolar disorders. Although it does not offer Open Access, its extensive coverage from 1999 to 2024 ensures that practitioners, researchers, and students have access to a wealth of knowledge critical for the development of effective therapeutic interventions. For those engaging with cutting-edge research in psychiatric care, BIPOLAR DISORDERS serves as an essential platform for knowledge dissemination and academic discourse.

Behavioral Psychology-Psicologia Conductual is a pioneering journal dedicated to advancing the field of psychology, with a specific focus on clinical and experimental domains. Published by FUNDACION VECA PARA AVANCE PSICOLOGIA in Spain, this journal serves as a vital resource for researchers, professionals, and students seeking to explore contemporary practices and theoretical frameworks in behavioral psychology. With its ISSN 1132-9483 and E-ISSN 1132-9483, the journal has established itself over a span of nearly three decades, from 1996 to 2024, contributing significantly to the academic discourse. While it currently holds a Q3 ranking in Clinical Psychology and a Q4 ranking in Experimental and Cognitive Psychology as of 2023, it aims to promote knowledge synthesis and innovative approaches to psychological research. Despite the absence of an open-access model, the journal's rigorous peer-review process ensures the dissemination of high-quality research that resonates with the needs of a growing audience dedicated to enhancing psychological practice and theory.

Neuropsychiatria i Neuropsychologia is a pivotal journal dedicated to the exploration of behavioral neuroscience, neuropsychology, and psychiatry, published by TERMEDIA PUBLISHING HOUSE LTD in Poland. This journal, with an ISSN of 1896-6764, has been a significant contribution to the scientific community since its inception in 2009 and continues to converge its findings until 2024. While it operates under a traditional access model, its commitment to disseminating research in these critical fields is unwavering. The journal currently holds a Q4 classification in multiple categories including Behavioral Neuroscience and Neuropsychology, reflecting its growing influence in the landscape of mental health studies. With Scopus rankings displaying a percentile standing in the bottom quartile, Neuropsychiatria i Neuropsychologia presents an opportunity for authors and researchers to contribute and engage with emerging findings in psychiatry and behavioral science. By fostering scholarly communication and collaboration, this journal serves as a valuable resource for researchers, professionals, and students seeking to advance their understanding and knowledge within these vital areas of study.

Molecular Autism, published by BMC in the United Kingdom, is a premier open-access journal dedicated to publishing high-quality research on the molecular and genetic factors contributing to autism spectrum disorders. Since its inception in 2010, the journal has established itself as a vital resource for researchers and clinicians, offering insights into the developmental biology, neuroscience, and psychiatric dimensions of autism. With an impressive impact factor and rankings placing it in the Q1 category across multiple relevant fields such as Developmental Biology, Developmental Neuroscience, Molecular Biology, and Psychiatry and Mental Health, it serves as a critical platform for the dissemination of innovative research and interdisciplinary collaboration. The journal encourages open dialogue through its commitment to making research freely accessible, thereby advancing knowledge and fostering advances in the understanding of autism. By bridging diverse disciplines and engaging with cutting-edge research, Molecular Autism aims to enhance our understanding of autism's complexities and inform future therapeutic approaches.

Journal of Cognitive Enhancement, published by SpringerNature, is a premier academic platform dedicated to advancing knowledge in the fields of Cognitive Neuroscience, Behavioral Neuroscience, and Experimental Psychology. With an electric combination of rigorous research and innovative practice, this journal has established itself as an essential resource for researchers, professionals, and students interested in understanding the mechanisms behind cognitive enhancement and its implications for mental health and cognitive function. As of 2023, it is recognized in the Q2 and Q3 quartiles across several categories, demonstrating its solid impact in the academic community, particularly with an impressive Scopus ranking of #27/76 in Neuropsychology and Physiological Psychology. Operating in a competitive landscape, the Journal of Cognitive Enhancement fosters open dialogue and collaboration through valuable contributions to cognitive research, facilitating insights that are crucial for practical applications in clinical and educational settings. While specific open access options are currently not defined, we encourage all interested scholars to explore the rich database of published works dating from 2017 to 2024, contributing to this dynamic field of study.

JOURNAL OF ADDICTIVE DISEASES, published by ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD, serves as a pivotal platform for researchers, clinicians, and students in the realms of clinical psychology, psychiatry, and addiction studies. With a distinguished history dating back to its inception in 1991, this journal spans critical research developments with its current scope covering converged years from 2018 to 2024, ensuring a robust repository of knowledge. Notably, it holds a respectable impact factor and is categorized in Q2 quartiles across several disciplines including Clinical Psychology, Medicine (miscellaneous), and Psychiatry and Mental Health for 2023, reflecting its impactful contributions to the scientific community. Despite the journal not currently offering Open Access, it remains highly ranked, occupying positions in the top percentiles of Scopus rankings. This journal emphasizes the importance of disseminating high-quality research focused on addictive behaviors and diseases, thereby addressing vital clinical and public health challenges.

Iranian Journal of Psychiatry and Behavioral Sciences, published by BRIEFLAND, is a pivotal platform for scholars and practitioners in the fields of psychiatry and behavioral sciences. With its ISSN 1735-8639 and E-ISSN 1735-9287, this journal primarily caters to the Iranian context while fostering a global dialogue on contemporary issues in mental health, behavioral neurology, and biological psychiatry. Since its inception in 2007, the journal has committed to disseminating high-quality research and reviews, thereby contributing to its categorization in the fourth quartile (Q4) for both Behavioral Neuroscience and Biological Psychiatry as of 2023. Although currently lacking an open access model, the journal's accessibility to critical research discussions is vital for enhancing knowledge among researchers, professionals, and students alike. With emerging relevance in the Iranian mental health landscape, it aims to bridge gaps in understanding and promote evidence-based practices from 2007 to 2024 and beyond.

The International Journal of Clinical and Health Psychology, published by Elsevier Science Inc, stands at the forefront of psychological research, delivering high-quality insights since its inception in 2005. With an impressive impact factor, this Open Access journal has established itself as a pivotal platform for scholars in the field, particularly noted for its ranking of Q1 in Clinical Psychology and a commendable 95th percentile in Scopus rankings. The journal focuses on advancing the understanding of psychological principles in clinical and health contexts, making it an essential resource for researchers, practitioners, and students alike. As the scope includes a wide array of topics related to clinical psychology, it aims to foster innovative research and promote the translation of scientific findings into practical applications, thereby enhancing psychological well-being globally. Since transitioning to Open Access in 2013, it has further increased its reach and accessibility, ensuring that important research is available to a diverse audience.

VERHALTENSTHERAPIE, published by KARGER, is an authoritative journal in the field of Clinical Psychology and Psychiatry, with its ISSN being 1016-6262 and E-ISSN 1423-0402. This esteemed journal, based in Basel, Switzerland, has been disseminating valuable research insights since its inception in 1991, with a projected convergence up to 2024. Targeting healthcare professionals, researchers, and students, VERHALTENSTHERAPIE focuses on the latest advancements in behavioral therapy, offering a platform for the exchange of rigorous studies and innovative practices. The journal currently holds a Q3 ranking in Clinical Psychology and a Q4 ranking in Psychiatry and Mental Health for 2023, further asserting its role in informing clinical practice and research in these critical areas. Though it does not operate under an open access model, the journal ensures that high-quality research is made available, contributing significantly to both theoretical and practical aspects of mental health. By publishing cutting-edge research, case studies, and reviews, VERHALTENSTHERAPIE aims to foster knowledge and understanding that enriches the fields of psychology and psychiatry.

PSYCHIATRY AND CLINICAL NEUROSCIENCES is a leading journal in the fields of psychiatry and clinical neurology, published by Wiley. With a commendable impact factor and a position within the prestigious Q1 quartile across multiple relevant categories—including Medicine (Miscellaneous), Neurology, and Psychiatry and Mental Health—this journal stands out for its rigorous peer-reviewed content that addresses critical issues in mental health and neurological disorders. Established in 1933, the journal has a rich history of contributing impactful research that guides both clinical practice and academic inquiry. Although it is not an open-access journal, its high relevance is underscored by its Scopus rankings, with notable percentiles in Psychiatry and Neurology, making it a vital resource for researchers, clinicians, and students looking to stay abreast of the latest advancements. Located in the United Kingdom, PSYCHIATRY AND CLINICAL NEUROSCIENCES aims to bridge the gap between theory and practical application, fostering a comprehensive understanding of the complex interplay between mental health and neurological conditions.